[ad_1]
Adaptive Biotechnologies ADPT reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Adaptive Biotechnologies beat estimated earnings by 13.95%, reporting an EPS of $-0.37 versus an estimate of $-0.43.
Revenue was up $5.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 4.32% drop in the share price the next day.
Here’s a look at Adaptive Biotechnologies’s past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.45 | -0.45 | -0.42 | -0.42 |
EPS Actual | -0.44 | -0.43 | -0.40 | -0.35 |
Revenue Estimate | 37.71M | 36.37M | 36.64M | 31.26M |
Revenue Actual | 38.62M | 37.93M | 39.47M | 38.51M |
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.45 | -0.45 | -0.42 | -0.42 |
EPS Actual | -0.44 | -0.43 | -0.40 | -0.35 |
Revenue Estimate | 37.71M | 36.37M | 36.64M | 31.26M |
Revenue Actual | 38.62M | 37.93M | 39.47M | 38.51M |
To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.